NEWS

Arch Biopartners' lead anti-bacterial drug candidate to enter investigator-sponsored Phase I human trial

Saturday, Apr 15, 2017

Arch Biopartners' lead anti-bacterial drug candidate ab569 to enter investigator-sponsored Phase I human trial.

Arch Biopartners- Arch has initiated GMP manufacturing of AB569 drug product that is required for trial.

 

Source: reuters.com

Other News